As observed in RA patients undergoing anti-TNF-α infliximab therapy [39], a single infusion of this biologic agent did not lead to significant changes in the serum levels of adiponectin in patients with AS [37]. The gene discussed is TNF; the disease is rheumatoid arthritis.